Literature DB >> 18100441

Streptomycin resistance in pulmonary tuberculosis.

J CROFTON, D A MITCHISON.   

Abstract

Entities:  

Keywords:  STREPTOMYCIN/therapy; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1948        PMID： 18100441      PMCID： PMC2092236          DOI： 10.1136/bmj.2.4588.1009

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  RECENT ADVANCES IN BACTERIAL GENETICS.

Authors:  S E Luria
Journal:  Bacteriol Rev       Date:  1947-03

2.  SENSITIVITY OF THE TUBERCLE BACILLUS TO STREPTOMYCIN BEFORE AND DURING SPECIFIC THERAPY.

Authors:  J F Sadusk; W E Swift; E Falco; J Vadney
Journal:  J Clin Invest       Date:  1948-03       Impact factor: 14.808

3.  The bactericidal action of streptomycin.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1948-02-28
  3 in total
  38 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  [On the virulence of resistant tubercle bacteria].

Authors:  S WEIDMANN
Journal:  Klin Wochenschr       Date:  1955-01-01

Review 3.  Understanding the contribution of environmental factors in the spread of antimicrobial resistance.

Authors:  Stephanie Fletcher
Journal:  Environ Health Prev Med       Date:  2015-04-29       Impact factor: 3.674

4.  Drug-resistant tuberculosis: what are the treatment options?

Authors:  Amr S Albanna; Dick Menzies
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

5.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 6.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

Review 7.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

8.  Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.

Authors:  Dennis Falzon; Neel Gandhi; Giovanni B Migliori; Giovanni Sotgiu; Helen S Cox; Timothy H Holtz; Maria-Graciela Hollm-Delgado; Salmaan Keshavjee; Kathryn DeRiemer; Rosella Centis; Lia D'Ambrosio; Christoph G Lange; Melissa Bauer; Dick Menzies
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

9.  Evolution of Resistance to Continuously Increasing Streptomycin Concentrations in Populations of Escherichia coli.

Authors:  Fabrizio Spagnolo; Conrad Rinaldi; Dannah Rae Sajorda; Daniel E Dykhuizen
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

10.  Increased survival of antibiotic-resistant Escherichia coli inside macrophages.

Authors:  Migla Miskinyte; Isabel Gordo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.